We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 19.14 | 1.65% | 1,175.995 | 1,175.25 | 1,175.74 | 1,177.00 | 1,155.305 | 1,167.31 | 262,331 | 18:43:58 |
From Aug 2019 to Aug 2024
By Pietro Lombardi
Sanofi SA will raise up to $11.7 billion by selling almost its entire 20.6% stake in U.S. biotech company Regeneron Pharmaceuticals Inc.
The French pharmaceutical major said late Tuesday that it is selling 11.8 million shares in the U.S. company at $515 each, while Regeneron will buy back $5 billion of its shares.
Sanofi has given the underwriters the option to buy up to 1.2 million additional shares.
After the two-part transaction, and assuming the option is fully exercised, Sanofi will keep 400,000 shares in the U.S. company, cashing $11.7 billion overall.
"Sanofi expects to use the net proceeds of the offering and the repurchase to further execute on its strategy to drive innovation and growth," it said.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com
(END) Dow Jones Newswires
May 27, 2020 01:29 ET (05:29 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Regeneron Pharmaceuticals Chart |
1 Month Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
